8-K - Vaxart, Inc. - 1.01 / 3.02 / 7.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001437749-26-012623

Filing Date: 2026-04-17

Accepted: 2026-04-17 08:30:16

Documents: 15

Period of Report: 2026-04-16

Items: Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Vaxart, Inc. (Filer) CIK : 0000072444 (see all company filings) EIN. : 591212264 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 26869515 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | FORM 8-K | vxrt20260417_8k.htm iXBRL | 8-K

2 | EXHIBIT 10.1 | ex_947186.htm | EX-10.1

3 | EXHIBIT 10.2 | ex_947187.htm | EX-10.2

4 | EXHIBIT 99.1 | ex_947188.htm | EX-99.1